Categories: NewsPharmaceutical

MedCana Highlights Recent Acquisitions and the Multiple Cannabis Licenses Associated with Each

The licenses will add $1.6 million to our total Assets for the 3rd Quarter.

AUSTIN, TX / ACCESSWIRE / October 9, 2024 / MedCana (OTC PINK:SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces significant and multiple acquisitions, along with multiple cannabis licenses associated with each, bolstering the company’s cannabis portfolio globally.

With these recent acquisitions, MedCana has rapidly solidified its position as a leading force in the Cannabis industry. Due to the large number of acquisitions completed, the company would like to break down each acquisition and the cannabis license associated with each to give shareholders a better idea of the scope and magnitude of these new additions to the MedCana portfolio.

MedCana has acquired a total of 23 licenses comprising:

Cannabicolombia group s.a.s. 100% acquired, Cannehealth Business s.a.s. 100% Organic Leaves S.A.S. 100% acquired, Remedium S.A.S 100% acquired Royal Cannabis S.A.S 100% acquired, Vital Cannabis S.A.S 100% acquired, Elemental Genetics S.A.S 100% acquired.

Medcana has also acquired a controlling stake in Eko2o Environmental Solutions S.A.S. of Medellin, Antioquia. This company is focused on developing infrastructure for agriculture, primarily greenhouse construction and irrigation systems in Colombia and South America. The company recently announced its continued growth and expansion as a critical infrastructure supplier for some of Colombia’s largest flower producers. The company also enhances its support and sales operations with international partnerships, notably Danziger International.

Gabriel Diaz, CEO of MedCana, commented: “The acquisitions we have made put Medcana in a position to succeed and ensure profitably.”

This marks a new era in MedCana’s operations as the company continues to build its presence on the global stage and explore further avenues for offering its premium cannabis products.

About SFWJ/Medcana

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings.

For more information, please visit: www.MedCana.net

Or connect with us via:
MedCana | LinkedIn
https://X.com/@MedcanaCo

SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:
Jose Gabriel Diaz, CEO
www.medcana.net
info@medcana.co

SOURCE: Software Effective Solutions

View the original press release on accesswire.com

Staff

Recent Posts

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…

3 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…

6 hours ago

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

6 hours ago

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

6 hours ago

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…

6 hours ago